Investors
Statement of Cash Flows
Quarterly Statement Q1 2025
| Q1 | ||
| Million € | 2025 | 2024 |
| Net income |
808 |
1,368 |
| Depreciation and amortization of property, plant and equipment and intangible assetsa |
981 |
965 |
| Equity-accounted income |
345 |
-267 |
| Other noncash items |
-5 |
71 |
| Gains (-) / losses (+) from the disposal of noncurrent assets and securities |
-7 |
-27 |
| Dividends received from equity-accounted investments |
28 |
13 |
| Changes in inventories |
-443 |
-317 |
| Changes in accounts receivable, trade |
-2,310 |
-2,795 |
| Changes in accounts payable, trade |
-209 |
-86 |
| Changes in provisions |
835 |
1,152 |
| Changes in other operating assets |
-504 |
-120 |
| Changes in other operating liabilities and pension provisions |
-499 |
-471 |
| Cash flows from operating activities |
-982 |
-513 |
|
|
|
|
| Payments made for property, plant and equipment and intangible assets |
-816 |
-943 |
| Payments made for financial assets and securities |
-184 |
-157 |
| Payments made for investments in equity instruments |
-16 |
-9 |
| Payments made for acquisitions |
– |
-34 |
| Payments received for divestitures |
3 |
16 |
| Payments received from the disposal of noncurrent assets and securities |
224 |
228 |
| Payments received from the disposal of equity instruments |
116 |
36 |
| Cash flows from investing activities |
-674 |
-862 |
|
|
|
|
| Capital repayments and other equity transactions |
– |
– |
| Additions to financial and similar liabilities |
1,902 |
2,416 |
| Repayment of financial and similar liabilities |
-812 |
-841 |
| Dividends paid |
– |
-37 |
| Cash flows from financing activities |
1,090 |
1,539 |
| Cash-effective changes in cash and cash equivalents |
-566 |
163 |
| Changes in cash and cash equivalents from foreign exchange rates and changes in the scope of consolidation |
-30 |
-1 |
| Cash and cash equivalents at the beginning of the periodb |
2,921 |
2,624 |
| Cash and cash equivalents at the end of the periodb |
2,325 |
2,786 |
a This item includes depreciation and amortization, impairments and reversals of impairments.
b As of December 31, 2024, and March 31, 2025, the cash and cash equivalents in the statement of cash flows differ from the value in the balance sheet due to the existence of disposal groups.